Keyword: Fidelity Biosciences

BioNTech biotech investments

6. BioNTech

BioNTech earmarked its considerable series A round for the development of its clinical pipeline, which includes mRNA-based cancer vaccines, a CAR-T treatment and a T cell receptor therapy for various solid tumors.